JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2007) 194, 55-61    DOI: 10.1677/JOE-07-0131
© 2007 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stigliano, A
Right arrow Articles by Toscano, V
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stigliano, A
Right arrow Articles by Toscano, V

Increased metastatic lymph node 64 and CYP17 expression are associated with high stage prostate cancer

A Stigliano1,3, O Gandini2, L Cerquetti1,3, P Gazzaniga2, S Misiti1,3, S Monti1, A Gradilone2, P Falasca1, M Poggi1, E Brunetti3, A M Aglianò2 and V Toscano1

1 Endocrinology II Faculty of Medicine, University of Rome ‘La Sapienza’, Via Cassia, 600-00189 Rome, Italy
2 Department of Sperimental Medicine and Patology, University of Rome ‘La Sapienza’, Via di Grottarossa, 1035-00189 Rome, Italy
3 Research Center AFaR Hospital S. Pietro, Via le Regina Elena, 324-00161 Rome, Italy

(Requests for offprints should be addressed to A Stigliano; Email: antonio.stigliano{at}uniroma1.it)

The metastatic lymph node 64 (MLN64), which is localized in the human chromosome 17, encodes a protein with strong homology with steroidogenic acute regulatory protein. Its overexpression in human breast carcinomas and MLNs led to the hypothesis that this protein could be involved in intraneoplastic steroidogenesis. In the present study, we investigated the expression of MLN64 in prostate cancer, another hormone-dependent tumor, and compared its expression with that of CYP17, the gene encoding for the key enzyme of androgen synthesis. We investigated by RT-PCR the expression of MLN64 and CYP17 in 60 prostatic tumors and compared their expression with the stage of disease and the appearance of relapses in a follow-up of 24 months. We found MLN64 and CYP17 expressed in all samples examined, with significantly higher expression in neoplastic tissues with respect to normal tissues (NTs). Moreover, only in neoplastic but not in NTs, a positive linear correlation was found between MLN64 and CYP17 gene expression. MLN64 and CYP17 expression seems to correlate with high stage, high Gleason score and short relapse-free time. These data, for the first time, demonstrate the presence of MLN64 and CYP17 expression in both normal and neoplastic prostatic tissues. The biological role of MLN64 in human prostate and, particularly, in neoplastic tissue is still unclear. Our findings concerning MLN64 and CYP17 gene expression and their significant positive correlation in human prostate cancer may suggest their possible role in intraneoplastic autonomous steroidogenesis.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society for Endocrinology.